- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/52 - Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
Patent holdings for IPC class C07D 277/52
Total number of patents in this class: 118
10-year publication summary
|
7
|
14
|
13
|
15
|
13
|
8
|
6
|
5
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 189 |
11 |
| Step Pharma S.A.S. | 30 |
8 |
| Merck Sharp & Dohme LLC | 3750 |
7 |
| Vertex Pharmaceuticals Incorporated | 1599 |
5 |
| Chromocell Corporation | 48 |
3 |
| Dompé Farmaceutici S.p.A. | 269 |
3 |
| Eastern Virginia Medical School | 66 |
3 |
| Genzyme Corporation | 1244 |
3 |
| The Regents of the University of California, Santa Cruz | 19 |
3 |
| Thomas Jefferson University | 532 |
3 |
| Nodthera Limited | 37 |
3 |
| Bristol-myers Squibb Company | 4878 |
2 |
| Amgen Inc. | 4072 |
2 |
| Board of Regents, The University of Texas System | 5786 |
2 |
| President and Fellows of Harvard College | 5975 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2154 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 858 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 25 |
2 |
| Icagen, Inc. | 20 |
2 |
| Other owners | 48 |